An Open-label, Randomized, Controlled, 4-week Comparative Clinical Trial of Barnidipine Hydrochloride, a Calcium-channel Blocker, and Benazepril, an Angiotensin-converting Enzyme Inhibitor, in Chinese Patients with Renal Parenchymal Hypertension

By Chen X   Zheng F   Chen P   Tang L   Wei R   Yu Y   Su Y   Kikkawa T   Yamamoto M  

The Journal of International Medical Research, Vol. 34, Iss. 2, 2006-03 ,pp. : 121-128

Field House Publishing

Access to resources Recommend Favorite

The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension: Focus on Recent Studies

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Angiotensin II Type 1 Receptor Blocker/Calcium Channel Blocker Combination Therapy for Hypertension: Focus on a Single-pill Fixed-dose Combination of Valsartan and Amlodipine

By Miura S   Saku K  

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite

Which is the Optimal Antihypertensive Combination in Different Diseases, a Renin- Angiotensin-aldosterone System Inhibitor with a Diuretic or with a Calcium Channel Blocker?

By  

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3753-3765

Bentham Science Publishers

Access to resources Recommend Favorite

A 24-week Dose-titration Study of the Angiotensin-converting Enzyme Inhibitor Imidapril in the Treatment of Mild-to-moderate Essential Hypertension in the Elderly

By Dews I   VandenBurg M  

The Journal of International Medical Research, Vol. 29, Iss. 2, 2001-03 ,pp. : 100-107

Field House Publishing

Access to resources Recommend Favorite